In-Depth Insights into the Cardiac AI Monitoring And Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the cardiac ai monitoring and diagnostics market size evolved in recent years?
In the recent past, the market size of cardiac AI monitoring and diagnostic market has experienced a significant increase. The market that was valued at $1.71 billion in 2024 will escalate to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 26.4%. Factors such as the growing age demographics, surge in remote patient monitoring, uptick in healthcare spending, advancements in clinical research and validation surveys, and a heightened focus on preventive healthcare have all contributed to the remarkable growth during the historical period.
What are the predictions for the cardiac ai monitoring and diagnostics market size in the coming years?
The market for cardiac ai monitoring and diagnostics is anticipated to experience substantial growth in the near future, escalating to a value of $5.54 billion in 2023, with a compound annual growth rate (CAGR) of 26.6%. The anticipated growth during this prediction period can be ascribed to factors such as the surge in wearable and IoT devices, increased acceptance of telemedicine and remote surveillance, incorporation of big data analytics and predictive models, emphasis on patient-centric care, and remote patient interaction, along with advancements in healthcare infrastructure. Key market trends for this period encompass the assimilation of AI in wearable devices, individualized risk evaluation and treatment stratagems, predictive analysis for cardiovascular events, amalgamation of multiple data sources, and standards for interoperability and data integration.
Get your cardiac ai monitoring and diagnostics market report here!
What key factors are fueling the growth of the cardiac ai monitoring and diagnostics market?
The rise in cardiovascular illnesses is anticipated to spur the expansion of the cardiac AI surveillance and diagnostic industry. Cardiovascular illnesses (CVDs) encompass a range of maladies that pertain to the heart and blood vessels, which include cerebrovascular diseases, coronary artery diseases, rheumatic heart diseases, among others. These AI-influenced cardiac surveillance and diagnostic processes enhance early detection, evaluate risks, and administer customized treatment methods for cardiovascular maladies, thus bettering the health outcomes for patients. For instance, the British Heart Foundation, a cardiovascular research charity based in the UK, disclosed in September 2024 that approximately 7.6 million people in the UK are grappling with heart-related and circulatory diseases, with around 4 million men and 3.6 million women diagnosed with these conditions. They account for nearly 27% of all deaths in the UK which is about over 170,000 deaths each year, or approximately 480 deaths per day, equating to one death in every three minutes. Hence, the amplifying prevalence of cardiovascular diseases is fueling the growth of the cardiac AI surveillance and diagnostic market.
How is the global cardiac ai monitoring and diagnostics market divided into key segments?
The cardiac ai monitoring and diagnostics market covered in this report is segmented –
1) By Type: Cardiac Diagnostics, Cardiac Monitoring
2) By Product: Software, Hardware
3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD), Cardiac Arrhythmias, Ischemic Stroke, Other Applications
4) By End Users: Hospitals, Diagnostic Centers, Other End Users
Subsegments:
1) By Cardiac Diagnostics: ECG Analysis, Echocardiography Analysis, Cardiac Imaging, Biomarker Analysis
2) By Cardiac Monitoring: Wearable Cardiac Monitors, Remote Patient Monitoring Systems, Implantable Cardiac Devices, Continuous ECG Monitoring Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13820&type=smp
Who are the key firms paving the way for growth in the cardiac ai monitoring and diagnostics market?
Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.
Which trends are expected to transform the cardiac ai monitoring and diagnostics market?
In an attempt to consolidate their position in the cardiac AI monitoring and diagnostics industry, major enterprises are focused on the development of medically advanced technological devices such as artificial intelligence-incorporated implantable cardiac monitors. These devices offer continuous tracking of cardiac performance. For example, the Germany-based cardiovascular biomedical research and enterprise, Biotronik, declared in May 2023, that the BIOMONITOR IV implantable cardiac monitor (ICM), equipped with AI-based SmartECG technology, had received approval from the US Food and Drug Administration (FDA). The BIOMONITOR IV ICM features Biotronik’s ground-breaking AI-fueled SmartECG algorithm that can eradicate up to 86% of false identifications, while retaining 98% of actual episodes. This transformational technology enhances detection accuracy for medical professionals, allowing for a significant reduction in false positive alerts, and facilitating rapid and accurate diagnosis of specific cardiac conditions. In addition, BIOMONITOR IV uniquely identifies itself as the first ICM capable of distinguishing between premature ventricular contractions (PVCs) and premature atrial contractions (PACs).
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13820
What regions are contributing significantly to the growth of the cardiac ai monitoring and diagnostics market?
North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Hospital Robots Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hospital-robots-global-market-report
Smart Robots Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/smart-robots-global-market-report
Industrial Robots (Warehousing and Storage Robots) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
